Kennedy last week said Trump assured him he would get a role in The White House if he won the presidential election.

Ann-Hunter Van Kirk, Bloomberg Intelligence Senior Biopharmaceutical Analyst and co-author of the report, noted that improved ...

Check out some of the latest packging and processing solutions exhibitors plan to debut or showcase at PACK EXPO, set for Nov ...

Robert F. Kennedy Jr is known as a persistent critic of vaccine safety and is a longtime antagonist of the Food and Drug ...

SAN DIEGO, CA / ACCESSWIRE / November 6, 2024 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ('Ainos', or the 'Company'), an innovative healthcare company focused on advanced AI-driven point-of-care ...

You can give the liver-flavored tablets with or without food once a month ... This helpful reference includes all FDA- and EPA-approved parasite control products for small animals along with ...

FDA approves Autolus Therapeutics' Aucatzyl for adults with relapsed or refractory B-cell precursor acute lymphoblastic ...

Obe-cel was designed to increase T-cell persistence and reduce T-cell exhaustion and was shown to improve response rates and survival, particularly in patients with low leukemia burden.

Autolus Therapeutics said it received Food and Drug Administration approval of its treatment of acute lymphoblastic leukemia, or ALL, an aggressive blood and bone marrow cancer, for certain patients.

Canalevia®-CA1 is the first and only treatment for chemotherapy-induced diarrhea (CID) in dogs to receive any type of approval from the FDABy ...

Jaguar Health (JAGX) announced that the U.S. Food and Drug Administration has approved renewal of Canalevia-CA1. Canalevia-CA1, the ...